Oppenheimer analyst Suraj Kalia downgraded LeMaitre Vascular (NASDAQ: LMAT) from Outperform to Perform.The analyst comments: "4Q revenue was $55.7M, +14 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE